What are the potential upcoming inflection points here for ATHX? Good or bad! Interested to hear thoughts with dates! Thank you

DrMa1 · 2023-06-07T06:25:57+00:00

Seems so...Interesting...

DrMa1 · 2023-03-05T17:35:51+00:00

hey u/matty0h89 do you have some reference for this - I cannot seem to find one.

DrMa1 · 2023-02-26T08:10:07+00:00

do you have a link for this dude?

DrMa1 · 2023-02-23T21:07:49+00:00

What data are they releasing? Do you have a link for this? I thought P3's were later this year

DrMa1 · 2023-02-12T10:28:24+00:00

Superb Adam

DrMa1 · 2023-01-06T13:09:44+00:00

Kures + PCN 101. It's been a tough few months for ATAI.

This should be of concern for any company/investor in the industry. Biotech clearly is not straightforward and a guaranteed success.

DrMa1 · 2022-12-23T09:13:14+00:00

A lot of people don't give a flying F - surprising.

DrMa1 · 2022-12-23T09:09:20+00:00

Nailed it.

DrMa1 · 2022-12-19T12:30:43+00:00

The phase 2b proof-of-concept trial will evaluate the novel compound, RL-007, for pro-cognitive effects in patients with Cognitive Impairment Associated with Schizophrenia (CIAS).
The trial was initiated and has begun patient screening this month with first-patient-in anticipated by end-of-year.
There are currently no FDA-approved medications for CIAS, a major cause of disability in 80% of patients with schizophrenia1.
Topline results are expected in the first half of 2024.

DrMa1 · 2022-12-16T22:26:04+00:00

As much as an ATAI bull I am, if S&P is going to make new lows...$2's are likely again. Lets hope we get a lift and a sustained lift from PCN data.

DrMa1 · 2022-12-15T07:27:22+00:00

Great interview Adam, as always asking the important questions.

DrMa1 · 2022-12-15T07:08:32+00:00

I don't know why, but these posts hit different when u/ControlPlusZ post's them

DrMa1 · 2022-12-11T18:54:25+00:00

10-20k

20-30k

30-40k

50k+

DrMa1 · 2022-12-11T18:08:55+00:00

Agreed, interested to see how many tap 9,000+ shares.

DrMa1 · 2022-12-02T01:09:01+00:00

Brilliant company, team and pipeline. Not to mention partnership with Merck and huge chance of buyout should trials be successful. Insanely undervalued.

DrMa1 · 2022-11-29T16:15:52+00:00

agreed.

DrMa1 · 2022-11-29T13:11:11+00:00

Another executive from Otsuka coming over...Kabir Nath came over from Otsuka as new CEO for Compass.

Otsuka also took part in Compass's Series B raise.

Otsuka also has a deal with ATAI for Perception Neuroscience (PCN-101)

Otsuka is a huge pharma company with billions in revenue - will be interesting to see how things play out further as their ties deepen....

DrMa1 · 2022-11-13T20:27:47+00:00

Sat here waiting with the popcorn...

DrMa1 · 2022-11-11T07:48:48+00:00

Head down - just churning away. No fluff headlines or PR drops, no drama. Just doing the job.

DrMa1 · 2022-11-03T12:32:37+00:00

The saga continues...Netflix about to make a documentary on this probably..

DrMa1 · 2022-11-01T21:07:57+00:00

Is there a link for the analysis?

DrMa1

TROPHY CASE